Research on the Concomitant Use of Low-Dose Aspirin Products and Antisecretory Drugs at a Health Insurance Pharmacy

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
doi 10.5649/jjphcs.32.548
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Related search

The Low Dose Aspirin Controversy Solved at Last?

BMJ
1985English

Low-Dose Aspirin Use and Cancer Characteristics: A Population-Based Cohort Study

British Journal of Cancer
Cancer ResearchOncology
2013English

Points: A Regimen of Low Dose Aspirin

BMJ
1983English

Benefit of Low-Dose Aspirin and Non-Steroidal Anti-Inflammatory Drugs in Septic Patients

Critical Care
Critical CareIntensive Care Medicine
2012English

The Impact of Logarithmic Dose Banding of Anticancer Drugs on Pharmacy Compounding Efficiency at Ghent University Hospital

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2017English

Low-Dose Aspirin Use and Survival in Breast Cancer Patients: A Nationwide Cohort Study

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2017English

Low-Dose Aspirin Use and Survival in Breast Cancer Patients: A Nationwide Cohort Study

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2017English

Gastrointestinal Symptoms in Low-Dose Aspirin Users: A Comparison Between Plain and Buffered Aspirin

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2014English

Progress in Low Dose Health Risk Research

Mutation Research - Reviews in Mutation Research
MutagenesisHealthGeneticsToxicology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy